From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. General Medicine>
  4. Summary and Comment

Treating Alcoholism: No Magic Bullet

The FDA approved naltrexone for treatment of alcohol dependence based on proven efficacy in randomized trials. Nevertheless, questions remain about the importance of clinical setting, patient characteristics, and concomitant therapies in determining naltrexone's effectiveness. Researchers from the U.S. Department of Veterans Affairs studied naltrexone (given daily for 3 or 12 months) in a large, multicenter, placebo-controlled trial that included 627 veterans with alcohol dependence. All subjects received counseling based on the tenets of Alcoholics Anonymous, initially weekly and then monthly.

At 13 weeks, there was no significant difference in return to heavy drinking. At 1 year, there were no significant differences in percentage of drinking days or number of drinks per drinking day. In the 2 naltrexone groups, medication adherence (percentage of days that the medication bottle was opened) was 72% at 13 weeks and 43% to 44% at 1 year. Medication adherence, attendance at counseling, and AA participation were associated with improved outcomes, regardless of treatment assignment.

Comment: Editorialists point out that, in this study, naltrexone was ineffective in a population that comprised mainly men who had long-standing alcoholism and relatively little social support and who received minimal counseling; these patient characteristics contrast with those in prior studies that demonstrated naltrexone's efficacy. Can naltrexone cure alcoholism? Clearly, the answer is "no, not alone," and we shouldn't expect that any one drug could cure a complex, chronic medical illness. Nonetheless, the current results do not negate previous findings of modest efficacy when the drug is used with appropriate counseling in less severely affected patients.

— Richard Saitz, MD, MPH

Published in Journal Watch General Medicine January 4, 2002

Citation(s):

Krystal JH et al. Naltrexone in the treatment of alcohol dependence. N Engl J Med 2001 Dec 13; 345:1734-9.

Fuller RK and Gordis E. Naltrexone treatment for alcohol dependence. N Engl J Med 2001 Dec 13; 345:1770-1.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2002. Massachusetts Medical Society. All rights reserved.